GlaxoSmithKline to Extend its Consumer Healthcare Business by 2022
The GlaxoSmithKline plc (GSK), a global pharmaceutical company has recently announced the strategic separation of the company’s Consumer Health Business, is going to be completed by the mid of 2022, and the company GlaxoSmithKline is going to be focusing on the novel corona virus vaccines and also the specialty medicines. The shares of the company […]
Continue Reading